Viking Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Feb '25 Feb 20, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Market Capitalization	3,007	3,582	1,461	598	266	301	Upgrade
Market Cap Growth	145.09%	145.09%	144.27%	125.11%	-11.65%	-31.25%	Upgrade
Enterprise Value	2,294	2,840	1,167	471	106	114	Upgrade
Last Close Price	26.99	31.85	14.66	7.50	3.40	4.61	Upgrade
PB Ratio	5.09	5.09	5.34	4.96	1.78	1.68	Upgrade
P/TBV Ratio	5.09	5.09	5.34	4.96	1.78	1.68	Upgrade
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.00	0.00	Upgrade
Quick Ratio	32.93	32.93	18.92	7.08	23.02	20.48	Upgrade
Current Ratio	33.09	33.09	19.19	7.61	23.98	21.12	Upgrade
Return on Equity (ROE)	-17.90%	-17.90%	-34.79%	-39.67%	-24.65%	-15.15%	Upgrade
Return on Assets (ROA)	-14.78%	-14.78%	-23.47%	-23.19%	-14.90%	-9.86%	Upgrade
Return on Capital (ROIC)	-15.32%	-15.32%	-25.38%	-25.21%	-15.58%	-10.21%	Upgrade
Earnings Yield	-2.92%	-2.45%	-4.61%	-9.55%	-15.28%	-9.62%	Upgrade
FCF Yield	-	-3.94%	-6.71%	-13.22%	-5.30%	Upgrade
Buyback Yield / Dilution	-15.57%	-15.57%	-22.79%	0.47%	-6.34%	-0.89%	Upgrade
Total Shareholder Return	-15.57%	-15.57%	-22.79%	0.47%	-6.34%	-0.89%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.